38954799|t|CeO2 In Situ Growth on Red Blood Cell Membranes: CQD Coating and Multipathway Alzheimer's Disease Therapy under NIR.
38954799|a|Alzheimer's disease (AD) has a complex etiology and diverse pathological processes. The therapeutic effect of single-target drugs is limited, so simultaneous intervention of multiple targets is gradually becoming a new research trend. Critical stages in AD progression involve amyloid-beta (Abeta) self-aggregation, metal-ion-triggered fibril formation, and elevated reactive oxygen species (ROS). Herein, red blood cell membranes (RBC) are used as templates for the in situ growth of cerium oxide (CeO2) nanocrystals. Then, carbon quantum dots (CQDs) are encapsulated to form nanocomposites (CQD-Ce-RBC). This strategy is combined with photothermal therapy (PTT) for AD therapy. The application of RBC enhances the materials' biocompatibility and improves immune evasion. RBC-grown CeO2, the first application in the field of AD, demonstrates outstanding antioxidant properties. CQD acts as a chelating agent for copper ions, which prevents the aggregation of Abeta. In addition, the thermal effect induced by near-infrared laser-induced CQD can break down Abeta fibers and improve the permeability of the blood-brain barrier. In vivo experiments on APP/PS1 mice demonstrate that CQD-Ce-RBC combined with PTT effectively clears cerebral amyloid deposits and significantly enhances learning and cognitive abilities, thereby retarding disease progression. This innovative multipathway approach under light-induced conditions holds promise for AD treatment.
38954799	0	4	CeO2	Chemical	MESH:C030583
38954799	49	52	CQD	Chemical	-
38954799	78	97	Alzheimer's Disease	Disease	MESH:D000544
38954799	117	136	Alzheimer's disease	Disease	MESH:D000544
38954799	138	140	AD	Disease	MESH:D000544
38954799	371	373	AD	Disease	MESH:D000544
38954799	394	406	amyloid-beta	Gene	351
38954799	408	413	Abeta	Gene	351
38954799	433	438	metal	Chemical	MESH:D008670
38954799	439	442	ion	Chemical	MESH:D007477
38954799	484	507	reactive oxygen species	Chemical	MESH:D017382
38954799	509	512	ROS	Chemical	MESH:D017382
38954799	602	614	cerium oxide	Chemical	MESH:C030583
38954799	616	620	CeO2	Chemical	MESH:C030583
38954799	642	661	carbon quantum dots	Chemical	-
38954799	663	667	CQDs	Chemical	-
38954799	710	713	CQD	Chemical	-
38954799	714	716	Ce	Chemical	MESH:D002563
38954799	785	787	AD	Disease	MESH:D000544
38954799	900	904	CeO2	Chemical	MESH:C030583
38954799	944	946	AD	Disease	MESH:D000544
38954799	997	1000	CQD	Chemical	-
38954799	1031	1037	copper	Chemical	MESH:D003300
38954799	1078	1083	Abeta	Gene	351
38954799	1156	1159	CQD	Chemical	-
38954799	1175	1180	Abeta	Gene	351
38954799	1268	1271	APP	Gene	351
38954799	1272	1275	PS1	Gene	5663
38954799	1276	1280	mice	Species	10090
38954799	1298	1301	CQD	Chemical	-
38954799	1302	1304	Ce	Chemical	MESH:D002563
38954799	1346	1371	cerebral amyloid deposits	Disease	MESH:D058225
38954799	1559	1561	AD	Disease	MESH:D000544
38954799	Negative_Correlation	MESH:D002563	MESH:D058225
38954799	Association	MESH:D008670	MESH:D000544
38954799	Positive_Correlation	MESH:D017382	MESH:D000544
38954799	Negative_Correlation	MESH:C030583	MESH:D000544

